Eppendorf Tubes® BioBased
EppendorfEppendorf Tubes ® BioBased are a new era of laboratory tubes made with bio-based, eco-friendly polymer that doesn’t sacrifice quality or performance.
Eppendorf Tubes ® BioBased are a new era of laboratory tubes made with bio-based, eco-friendly polymer that doesn’t sacrifice quality or performance.
RNase Block Ribonuclease Inhibitor is a 50-kDa protein that specifically inhibits common eukaryotic RNases including RNase A, RNase B, and RNase C.
Specially treated Human Serum Albumin, optimized for human ES and iPS cell culture. Designed for optimal cryopreservation of hMSCs
In this guest editorial, Pascal Steffen-Lockhauserbäumer, Global Product Manager for timsTOF at Bruker Daltonics explores how spatial multiomics combines imaging with LC/MS to revolutionize biomolecular analysis, enabling high-resolution insights into disease mechanisms, immune response, and tissue structure, with applications in diagnostics and personalized medicine
Recognition underscores Bruker’s commitment to sustainability and innovation in microbial detection
Research at Karl Landsteiner University of Health Sciences offers new insight in brain connectivity and development
Resolian has established itself as a world-class leader in biopharmaceutical drug development through analytical excellence with over 500 scientists across three global labs.
Contrasting membrane for microbiological analysis
Could stronger collaboration from lab-to-frontline care be the key to advancing antimicrobial stewardship (AMS)?
Key topics included the health effects of plastics, tackling medical misinformation, and advancing clinical care with AI
Label-free and fluorescence isolation of microbiota, cultured bacteria, and yeast
Explore innovations and tools for clinical labs shaping the future of sepsis management, clinical mass spec, anticoagulant diagnostics, and more
As part of LabWeek, Dr. Umama Shahid shares her research on riboswitches and their potential to combat antimicrobial resistance
How is globalization impacting the transmission of infectious diseases and what response is required from global health networks for greater security?